Table 2 Summary of passive 3D nanoelectrode applications for cardiac electrophysiology
From: Advanced passive 3D bioelectronics: powerful tool for the cardiac electrophysiology investigation
Geometry | Fabrication method | Materials | Throughput | Access strategies | Maximum AP (mV) | Duration | Cells | Application | Refs. |
|---|---|---|---|---|---|---|---|---|---|
gMμEs | CVD, evaporation, photolithography, gold electroplating, etching | Ti-Au- SiO2 | 62 | Electroporation | 6 | 2–10 min | Rat primary cardiomyocytes | - | |
Vertical nanopillar | PECVD, FIB, photolithography | Pt-Ti-Si3N4-SiO2- Pt | 16 | Electroporation | 11.8 | 10 min | HL-1 cells | Drug screening | |
Nanopillar | CVD, EBL, FIB, etching | Pt-SiO2 | - | Electroporation | 25.15 | - | hPSC-CMs | Drug screening, Modeling disease | |
Nanopillar | FIB, deposition, etching | Au-SU8-Pt-SiO2 | 16 | Electroporation | 2.3 | ~10 min | HL-1 cells | Modeling disease | |
Nanopillar | ALD, photolithography, etching | PET-Al2O3-Au-Ti-SU8 | - | Electroporation | 0.2216 ± 0.2175 | - | Neonatal rat cardiomyocytes | Drug screening | |
IrOx nanotube | PECVD, EBL, photolithography, etching, deposition | Pt/Ti-Si3N4-SiO2-IrOx | 60 | Electroporation | 15 | ~60 min | HL-1 cells, primary rat cardiomyocytes | - | |
Vertical NW | PECVD, ALD, photolithography, etching | SiO2-Ti-Pt-SiO2 | 1024 | Electroporation | 20 | - | Rat ventricular cardiomyocytes | Drug screening | |
Ultrasharp NW | PECVD, EBL, photolithography, etching | Si-SiO2-Pt-SiO2 | 4 | Spontaneous penetration | 60 | - | iPSC-derived cardiovascular progenitor cells | - | |
3D plasmonic nanoelectrode | FIB, evaporation | Ti/Au-SU8-SiO2-Polyimide | - | Plasmonic optoporation | 1.5 | ~80 min | HL-1 cells | - | |
Nanovolcano | EBL, photolithography, deposition, etching | Ti-Pt-Ti-Au-Ti-SiO2-SU8 | 32 | Spontaneous penetration | 20 | Over 1 h | Primary rat cardiomyocytes | - | |
Nanobranched | Photolithography, hydrothermal growth | ZnO-Cr/Au or Pt-SU8 | 16/32 | Electroporation | ~5 | 105 min | Rat cardiomyocytes | - | |
Nanorods | Photolithography, hydrothermal growth | ZnO-Cr-Au(or Pt)-SU8 | 32 | Electroporation | ~5 | ~80 s | Neonatal rat cardiomyocytes | - | |
Nanocrown | FIB, deposition, etching | Cr-Ti-Pt-Si3N4-SiO2 | 58 | Electroporation | ~63 | ~60 min | hPSC-CMs | Drug screening | |
Nanotrap | Photolithography, deposition | PET-Ti-Au-SU8 | 32 | Electroporation | 4.32 | ~100 min | Neonatal rat cardiomyocytes | Drug screening | |
Nanowell | FIB, photolithography, deposition, etching | Si-Cr-Au-SiO2-Ni | 16 | Electroporation | ~0.1 | 10–20 min | HL-1 cells | - | |
Vertical nanotemplate | ALD, photolithography, etching | PET-Al2O3-Ti-Au-SU8 | 32 | Electroporation | 6.97 | 10 min | Primary neonatal rat cardiomyocytes | Drug screening | |
Hollow nanopillar | ALD, photolithography, etching | PET-Al2O3-Ti-Au-SU8 | 32 | Electroporation | 1.5 | Over 100 min | Primary rat cardiomyocytes | Drug screening | |
Supramolecular self-assemblies | Evaporation, deposition | Ti-Au-SiO2- SS-1, or SS-2, or SS-3 | 16 | Electroporation | ~4.0 | 10 min | Primary neonatal rat cardiomyocytes | - |